Valeo Pharma
(OTC) VPHIF
Valeo Pharma Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$53.38M
Net Income (TTM)
$32.12M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-5.23 (Low)
Dividend
$0.00
Beta (Volatility)
-5.23 (Low)
Price
$0.00
Volume
20,000
Open
$0.00
Price
$0.00
Volume
20,000
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.05
Dividend
$0.00
Beta (Volatility)
-5.23 (Low)
Price
$0.00
Volume
20,000
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.05
VPHIF News
VPHIF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Valeo Pharma
Industry
Pharmaceuticals
Sector
Health CareEmployees
125
CEO
Steven Saviuk, CPA
Website
www.valeopharma.comHeadquarters
Kirkland, QC H9H 4R9, CA
VPHIF Financials
Key Financial Metrics (TTM)
Gross Margin
24%
Operating Margin
-32%
Net Income Margin
-52%
Return on Equity
0%
Return on Capital
-82%
Return on Assets
-67%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$0.00
Shares Outstanding
0
Volume
20.00K
Short Interest
0.00%
Avg. Volume
96.71K
Financials (TTM)
Gross Profit
$13.08M
Operating Income
$17.23M
EBITDA
$11.39M
Operating Cash Flow
$15.70M
Capital Expenditure
$5.55M
Free Cash Flow
$21.25M
Cash & ST Invst.
$7.50M
Total Debt
$65.17M
Valeo Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$12.60M
-10.5%
Gross Profit
$3.43M
-19.6%
Gross Margin
27.25%
N/A
Market Cap
$0.00
N/A
Market Cap/Employee
N/A
N/A
Employees
70
N/A
Net Income
$8.19M
-40.3%
EBITDA
$3.68M
-109.7%
Quarterly Fundamentals
Net Cash
$62.96M
-15.9%
Accounts Receivable
$4.78M
-5.4%
Inventory
$4.94M
-61.7%
Long Term Debt
$24.43M
-61.8%
Short Term Debt
$45.65M
+64193.0%
Return on Assets
-67.48%
N/A
Return on Invested Capital
-82.30%
N/A
Free Cash Flow
$451.00K
+132.9%
Operating Cash Flow
$451.00K
+135.8%